5 Years Follow-up of Tak Protocol in Stone Recurrence/Regrowth after Kidney Stones Removal
DOI:
https://doi.org/10.14456/nujst.2020.21Keywords:
5 Years follow-up, Tak protocol, Stone recurrence, Kidney stones removalAbstract
Kidney stone is a risk factor for chronic kidney disease. Nephrocalcinosis or renal crystal deposition can lead to progressive loss of GFR that increase rate of complication and hospitalization. This research aims to evaluate 5-years follow-up of Tak Protocol in stone recurrence/regrowth, complication, hospitalization and reintervention after stone removal, compare with patients who loss follow-up. A retrospective cohort study of 106 patients with renal stone who after stone removal intervention were enrolled. All patients were divided in two groups. The protocol group (N = 70) was defined in patients who following up consistently through 5 years, and the loss follow-up group (N=36) serving as controls. Plain films KUB were used to detect stone recurrence and regrowth through 5-years follow-up. Complication, hospitalization and reintervention were reviewed from electronic medical recording database. 106 patients complete 5-years follow-up observation period. The average ages were 53.6 and 48.4 years for the protocol and loss follow-up groups, respectively. Most of 28 patients (40.0%) of protocol and 16 patients (44.4%) of loss follow-up were hypertension, whereas 25 patients (35.7%) and 15 patient (41.7%) were no underlying disease. In the stone free group, 90.5% of protocol group and 9.5% of loss follow-up group were still stone free at 60 months. In comparison with loss follow-up, stone free rate was 8.88(95%CI; 2.33-33.88, p<0.001) in protocol group. As a results of the residual stone group, protocol were 7.33(95%CI; 1.06-50.60, p=0.006) in stone free rate. Stone recurrence/size increased was found in 9.5% and 84.6% of protocol and loss follow-up group, while the result of stone size unchanged/decreased was no significant different in statistic. The recurrence and regrowth rates at one, two, three, four and five years were 2.39, 1.23, 0.84, 0.98 and 0.54 per 1,000 patient-months in the protocol group and were 7.11, 14.84, 6.57, 1.22 and 6.61 per 1,000 patient-months in the loss follow-up group, the IRR was 2.97 in the first year after intervention. The stone recurrence and regrowth were found in five years follow-up. Loss follow-up group was a higher rate than Tak protocol group. In conclusion, patient who has history of stone removal should be encouraged for lifestyle modification and made the appointment for following up at least 5 years. This protocol was shown the benefit in reducing complication and hospitalization rate.
References
Chongruksut, W., Lojanapiwat, B., Tawichasri, C., Paichitvichean, S., Euathrongchit, J., Ayudhya, V.C., & Patumanond, J. (2011). Kidney stones recurrence and regrowth after extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. Journal of the Medical Association of Thailand, 94(9), 1077-1083.
El-Nahas, A. R., El-Assmy, A. M., Madbouly, K., & Sheir, K. Z. (2006). Predictors of clinical significance of residual fragments after extracorporeal shockwave lithotripsy for renal stones. Journal of endourology, 20(11), 870-874.
Lojanapiwat, B., Tanthanuch, M., Pripathanont, C., Ratchanon, S., Srinualnad, S., Taweemonkongsap, T., … Lammongkolkul, S. (2011). Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. International Brazilian Journal of Urology, 37(5), 611-616.
Osman, M. M., Alfano, Y., Kamp, S., Haecker, A., Alken, P., Michel, M. S., & Knoll, T. (2005). 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. European Urology, 47(6), 860-864.
Ramaswamy, K., & Shah, O. (2014). Metabolic syndrome and nephrolithiasis. Translational Andrology and Urology, 3(3), 285-295.
Skolarikos, A., Straub, M., Knoll, T., Sarica, K., Seitz, C., Petrik, A., & Turk, C. (2015). Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. European Urology, 67(4), 750-763.
Tosukhowong, P., Boonlaa, C., Ratchanonb, S., Tanthanuchc, M., Poonpiromea, K., Supataravanicha, P., … Tungsanga, K. (2007). Crystalline composition and etiologic factors of kidney stone in Thailand: update 2007. Asian Biomedicine, 1(1), 87-95.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Naresuan University Journal: Science and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.